OUR STRATEGY Addressing Key Public Health Challenges Mérieux NutriSciences is dedicated to protecting global public health by preventing sanitary risks linked to the safety and quality of products. AND INTERNAL The Company has specialized in food safety for more than 50 years (thanks to Silliker legacy). Its expertise has then been extended to various sectors whose activities have a day-to-day impact on consumers’ health: cosmetics, consumer goods, and more. In addition to laboratory analyses, Mérieux NutriSciences provides auditing, consulting, contract research and education services. ORGANIZATION Mérieux NutriSciences also strives to improve nutrition through the expertise of its subsidiary Biofortis, an international applied research organization that has created unique methods to support breakthrough innovation for the health, nutrition and pharma industries. An Institut Mérieux Company OUR CORE BUSINESS Institut Mérieux is contributing its experience in biology to improve medicine and public healthacross the globe. As part of Institut Mérieux, Mérieux NutriSciences is dedicated to protecting consumers’ healthTo fight against infectious diseases and cancer, the Institut Mérieux designs and develops new throughout the world, by delivering a wide range of testing and consulting services to the food &approaches in the fields of diagnostics, immunotherapy, food safety and nutrition. nutrition, agrochemicals, pharma and cosmetics industries. Its three bio-industrial companies (bioMérieux, Transgene and Mérieux NutriSciences), working Being part of Institut Mérieux and a leader in our core business area, we are dedicated to serveclosely with its entities devoted to innovation (ABL Inc. and Mérieux Développement), have our customers and we are committed to consumers’ health. With this focus, our employees sharecontributed to the development of complementary solutions to protect consumers and serve common values: medicine and public health. INTEGRITY 59% bioMérieux EXCELLENCE 70% Mérieux NutriSciences ACCOUNTABILITY 60% Transgene INITIATIVE 8 9